Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07213063

Effects of Chronic Creatine and Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Oxidative Stress, Inflammation, Muscle Strength, and Body Composition in Individuals With Down Syndrome

Led by Universidad de Burgos · Updated on 2026-01-14

50

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

Sponsors

U

Universidad de Burgos

Lead Sponsor

E

European University Miguel de Cervantes

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating whether 8 weeks of daily supplementation with creatine monohydrate and beta-hydroxy-beta-methylbutyrate (HMB) can improve muscle strength, body composition, balance, cognitive function, and overall health in individuals with Down syndrome. This study is a randomized, placebo-controlled crossover trial that also includes nutritional education to support a balanced diet. The study aims to assess the effects of these supplements on oxidative stress and inflammation markers as well. Participants will take either 3 grams per day of creatine combined with 3 grams per day of HMB or a placebo (6 grams per day of inulin) orally for 8 weeks. After the first phase, participants will switch to the other supplementation for another 8 weeks. Nutritional education sessions will be provided throughout the intervention to promote healthy eating and lifestyle habits. Participants will undergo assessments before and after each supplementation period, including body composition scans using dual-energy X-ray absorptiometry (DXA) and bioimpedance, muscle strength tests like handgrip and lower limb strength, balance tests, cognitive function assessments, and blood tests to measure biomarkers of oxidative stress and inflammation. These evaluations will help researchers understand the physiological and functional effects of the supplements in people with Down syndrome. The total duration of participation spans across both 8-week supplementation periods with all tests conducted at baseline and at the end of each phase.

CONDITIONS

Brief Title

Effects of Chronic Creatine and Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Oxidative Stress, Inflammation, Muscle Strength, and Body Composition in Individuals With Down Syndrome

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Medical confirmation of Down syndrome (trisomy of chromosome 21)
  • Ability to perform basic physical tests such as standing up from a chair or walking without assistance
  • Informed consent obtained from both the participant and their legal representative according to current legislation
Not Eligible

You will not qualify if you...

  • Diagnosis of chronic kidney disease
  • Severe motor limitations preventing performance of required physical tests
  • Participation in another nutritional or supplementation intervention study within the last 6 months
  • Known allergy to creatine or to components of the placebo (inulin)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 8 weeks per supplementation phase

Participants receive daily supplementation with either creatine monohydrate and beta-hydroxy-beta-methylbutyrate or placebo for 8 weeks, along with nutrition education sessions to support a balanced diet.

Baseline and end-of-supplementation visits for each 8-week phase

Treatment

Duration - 8 weeks per supplementation phase

Participants cross over to the alternate supplementation (creatine and HMB or placebo) for another 8 weeks, continuing nutrition education.

Baseline and end-of-supplementation visits for each 8-week phase

Trial Site Locations

Total: 1 location

1

Universidad de Burgos

Burgos, Burgos, Spain, 09003

Actively Recruiting

Loading map...

Research Team

A

Alba Abia Heras, Nutrition and Dietetics

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

PREVENTION

Number of Arms

2

Similar Trials

Adapting the RDAD Intervention for Individuals With Down Syn...

Down Syndrome (DS)

Actively Recruiting

1 location

Compassionate Use Study of Epi-ON Corneal Collagen Crosslink...

Down Syndrome (DS)

Actively Recruiting

12 locations

Effect of a Short-term Multi-strain Probiotic Supplementatio...

Sports Nutrition

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here